Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of April 19 to 23, 2021. This […]
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of April 19 to 23, 2021. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.
CDC Panel Recommends Resuming Use of J&J COVID-19 Vaccine
FRIDAY, April 23, 2021 (HealthDay News) — The United States should resume administering the Johnson & Johnson COVID-19 vaccine, a key advisory panel for the Centers for Disease Control and Prevention voted on Friday.
Pfizer and Moderna Vaccines Effective Against New NYC Variant
FRIDAY, April 23, 2021 (HealthDay News) — The Pfizer-BioNTech and Moderna COVID-19 vaccines protect against serious illness and death from the coronavirus variant first identified in New York City, two new studies show.
Few SARS-CoV-2 Vaccine Breakthrough Infections Reported at SNFs
FRIDAY, April 23, 2021 (HealthDay News) — Few cases of severe acute respiratory syndrome coronavirus 2 infections have been reported at skilled nursing facilities among those with at least 14 days since receipt of the second dose of a two-dose COVID-19 vaccine series, according to research published in the April 21 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Single-Dose Ad26.COV2.S Effective Against COVID-19
FRIDAY, April 23, 2021 (HealthDay News) — A single dose of human adenovirus type 26 vector encoding full-length severe acute respiratory syndrome coronavirus 2 spike protein protects against moderate- to severe-critical and severe-critical COVID-19, according to a study published online April 21 in the New England Journal of Medicine.
Severe Maternal Morbidity, Mortality Up With COVID-19 in Pregnancy
FRIDAY, April 23, 2021 (HealthDay News) — COVID-19 in pregnancy is associated with increased severe maternal morbidity and mortality, according to a study published online April 22 in JAMA Pediatrics.
No Obvious Safety Signals ID’d for mRNA COVID-19 Vaccine in Pregnancy
THURSDAY, April 22, 2021 (HealthDay News) — Preliminary findings indicate no obvious safety signals for pregnant women who receive mRNA COVID-19 vaccines, according to a study published online April 21 in the New England Journal of Medicine.
One COVID-19 Vaccine Dose Wasted for Every 850 Used: CDC Data
THURSDAY, April 22, 2021 (HealthDay News) — One dose of COVID-19 vaccine was thrown out for every 850 doses administered in the United States, according to Centers for Disease Control and Prevention data up to March 29.
Fake Pfizer COVID-19 Vaccines Being Sold Online
THURSDAY, April 22, 2021 (HealthDay News) — Counterfeit versions of the Pfizer COVID-19 vaccine are being sold online, the company warns.
Biden Gives Businesses Incentives to Help Workers Get COVID-19 Shots
Significant Association ID"d Between Hepatitis C, Overactive Bladder .jpg)
Study Looks at Barriers to Initiation of Rotavirus Vaccine 
~16 Percent of COVID Cases Develop Postacute Sequelae of SARS-CoV-2 
Obstructive Sleep Apnea Tied to Nearly Doubled Risk for Flu, COVID-19 in Childhood 
Adenotonsillectomy Tied to Increase in Respiratory Tract Infections in Children 
Physical Exams May Not Reliably Diagnose Pediatric Pneumonia .jpeg)
Flu Treatment With Oseltamivir Linked to Reduced Risk for Pediatric ICU Admissions, Length of Stay 
AAP Releases Influenza Vaccine Recommendations for All Children 6 Months and Older 
